Clinical Trials
7 trialsNCT05741372 2026-01-13
A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis
Boehringer Ingelheim
Phase NA Completed
NCT03864042 2024-09-27
Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors
Pfizer
Phase 1 Completed
NCT01011478 2023-08-16
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
NSABP Foundation Inc
Phase 3 Terminated
NCT05045638 2023-08-14
Effect of Coadministration of Sotorasib on the Pharmacokinetics of Rosuvastatin in Healthy Participants
Amgen
Phase 1 Completed
NCT01299038 2020-02-05
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02114697 2018-09-11
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
Emory University
Phase 4 Terminated
NCT02317016 2018-07-31
Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer
AstraZeneca
Phase 1 Completed